Drug modeling software company Simulations Plus Inc. enjoyed an increase in revenue compared to last year, while earnings per share remained flat …
read source

Drug modeling software company Simulations Plus Inc. enjoyed an increase in revenue compared to last year, while earnings per share remained flat …
read source